MedPath

Treatment of nasolacrimal duct obstructio

Not Applicable
Conditions
primary acquire nasolacrimal duct obstruction.
Acute and unspecified inflammation of lacrimal passages
Registration Number
IRCT201205216388N2
Lead Sponsor
Research Deputy of Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

All patient with primary acquire nasolacrimal duct obstruction Exclusion criteria: History of surgery on nasolacrimal duct, Secondary obstruction in nasolacrimal duct

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The degree of nasolacrimal duct obstruction. Timepoint: Every 6 weeks. Method of measurement: MUNK scoring system.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath